TRIBVN Healthcare is very proud to have been selected to be part of the “EIT Health Bridgehead Europe programme” in 2020.
This one-year program, funded by European Union, is designed to support innovative European Medtechs in their international development. It connects start-ups with local clusters (known as CATalysers) in order to support and leverage company investments in the target territories.
Medical Valley and Start-Up Campus accompany TRIBVN Healthcare in its commercial development.
TRIBVN Healthcare has decided to work with Catalysers, Medical Valley in Germany and Start-Up Campus in Hungary to implement its commercial strategy and access to the German and Eastern European markets. These territories are priority markets in the digital transformation of cancer diagnosis, with many laboratories in transition.
This enables TRIBVN Healthcare to complete its commercial development in Europe and to make its expertise and products accessible to new customers. It is this ambition and the coherence of the application file that was recognized by the Bridgehead Europe program evaluation committee.
The teams started working together this summer: see you in a year’s time in Munich and Budapest!